Net Loss Per Share (Tables)

6 Months Ended

Jun. 30, 2021

Net Loss Per Share

Schedule of basic and diluted net loss per share

	Three Months Ended June 30,				Six Months Ended June 30,
(In thousands, except per share data)	2021		2020		2021		2020
Numerator:
Net loss attributable to CASI Pharmaceuticals, Inc.	$	(6,946)	$	(8,694)	$	(20,829)	$	(17,135)
Denominator:
Weighted average number of common shares		139,797		100,921		132,352		99,847
Denominator for basic and diluted net loss per share calculation		139,797		100,921		132,352		99,847
Net loss per share
— Basic and diluted	$	(0.05)	$	(0.09)	$	(0.16)	$	(0.17)